Anzu
Founded in 2010, Anzu offers a range of HIPAA compliant software solutions tailored for the medical industry, including a collaborative medical community platform and a clinical trial platform.
Company History
Anzu was founded in 2010 with a focus on providing HIPAA compliant software solutions tailored for the medical industry. Over the years, Anzu has built a variety of platforms and services to support clinical trials, data visualization, and secure communication within the healthcare sector. Their partnerships with EVE Health Systems and other collaborators have enabled them to integrate advanced technology and meet industry standards effectively.
HIPAA Compliant Software Solutions
Anzu offers a range of HIPAA compliant software solutions designed to meet the needs of the medical industry. Their projects include a collaborative medical community platform, a clinical trial platform, and various data visualization and analysis tools. A focus on security and compliance ensures that their software adheres to stringent privacy regulations, making it a reliable choice for healthcare professionals and institutions.
Collaborative Medical Community Platform
One of Anzu's key offerings is a collaborative medical community platform that allows users to publish content, bookmark videos, and tag metadata. This platform facilitates knowledge sharing and collaboration among medical professionals, fostering an environment of continuous learning and development. With patented video bookmarking and other unique features, it helps streamline the dissemination of medical information.
Clinical Trial Platform
Anzu provides a HIPAA compliant clinical trial platform that integrates mobile technology, Laboratory Information Management Systems (LIMS), and multimedia elements. This platform simplifies the process of conducting clinical trials by offering real-time processing and delivery of lab results through a secure mobile app. It also supports secure communications between clinical study team members, including site managers, principal investigators, and patients, ensuring a smooth and efficient trial process.
Immunity Management System for COVID-19
In response to the COVID-19 pandemic, Anzu developed an immunity management system for SARS-CoV-2. This system features a LIMS agnostic interface and a mobile application, allowing healthcare providers to manage and track immunity-related data effectively. The platform is designed to integrate seamlessly with existing LIMS, offering flexibility and ease of use for medical institutions.